Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-15

Clinical Trial Update: Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study [NA]

View source ↗

Summary

This clinical trial update describes a study on correlating arrhythmia mechanisms and substrate to ablate persistent atrial fibrillation, currently listed as ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Persistent Atrial Fibrillation | NA | Status: ACTIVE_NOT_RECRUITING